No evidence for autoimmunity in schizophrenia

Journal of Autoimmunity

Volumn 9, Issue 5, 1996, Pages 661-666

  Schattner, A ^a,d   Cori, Y ^a   Hahn, T ^a,b   Sirota, P ^c  

^a KAPLAN HOSPITAL   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c ABARBANEL MENTAL HEALTH CENTER   (Israel)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell mediated cytotoxicity; Interferon; Natural rheumatoid arthritis; Oligo adenylate synthetase; Schizophrenia; Tumour necrosis factor

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; CD4 ANTIGEN; CD8 ANTIGEN; INTERFERON; NEOPTERIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; AUTOIMMUNITY; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCHIZOPHRENIA; T LYMPHOCYTE SUBPOPULATION;

EID: 0030272811     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1996.0086     Document Type: Article

References (48)

1. 1. Carpenter W.T. Jr, Buchanan R.W. 1994. Schizophrenia. N. Engl. J. Med. 330: 681-690
2. 2. Knight J.G. 1985. Possible autoimmune mechanisms in schizophrenia. Integr. Psychiatry 3: 1314-143
3. 3. Kirch D.G. 1993. Infection and autoimmunity as etiologic factors in schizophrenia: a review and reappraisal. Schizophr. Bull. 19: 355-370
4. 4. Sirota P. 1990. Is schizophrenia an autoimmune disease? Isr. J. Med. Sci. 26: 694-697
5. 5. Waltrip R.W. II, Carrigan D.R., Carpenter W.T. Jr. 1990. Immunopathology and viral reactivation: a general theory of schizophrenia. J. Nerv. Ment. Dis. 178: 729-38
6. 6. Kaufman C.A., Ziegler R.J. 1988. The viral hypothesis of schizophrenia. In A.K. Sen, T. Lee eds. Receptors and ligands in psychiatry. Cambridge University Press, Cambridge, pp 187-208
7. 7. Meltzer H.Y. 1987. Biological studies in schizophrenia. Schizophr. Bull. 13: 77-111
8. 8. De Lisi L.E., Crow T.J. 1986. Is schizophrenia a viral or immunologic disorder? Psychiatr. Clin. North Am. 9: 115-132
9. 9. Schattner A., Wallach D., Merlin G. 1981. Assay of an interferon induced enzyme in white blood cells as a diagnostic aid in viral diseases. Lancet 2: 497-500
10. 10. Schattner A., Revel M. 1988. Monitoring of interferon therapy by assay of interferon-induced (2′-5′) oligo A synthetase in human peripheral white blood cells. In Clinical aspects of interferons. M. Revel ed. Kluwer Academic Publishers, Boston, pp 271-283
11. 11. Hahn T., Schattner A., Handzel Z.T., Levin S., Bentwich Z. 1989. Possible role of natural cytotoxic activity in the pathogenesis of AIDS. Clin. Immunol. Immunopathol. 50: 53-61
12. 12. Schattner A., Lachmi M., Livne A., Pras M., Hahn T. 1991. Tumor necrosis factor in familial Mediterrean fever. Am. J. Med. 90: 434-438
13. 13. Spitzer R.L, Endicott J., Robins E. 1978. Research diagnostic criteria: rationale and reliability. Arch. Gen. Psych. 35: 773-782
14. 14. Werner E.R., Bichler A., Daxenbichler G., Fuchs D., Fuith L.C., Hausen A., Hertzel H., Reibnegger G., Wachter H. 1987. Determination of neopterin in serum and urine. Clin. Chem. 33: 62-66
15. 15. Bentwich Z., Saxinger C., Ben-Ishay Z., Burstein R., Berner Y., Pecht M., Trainin N., Levin S., Handze Z. 1987. Immune impairments and antibodies to HTLV 3/LAV in asymptomatic male homosexuals in Israel: Relevance to the risk of AIDS. J. Clin. Immunology 7: 376-380
16. 16. Muller N., Hofschuster E., Ackenheil M., Eckstein R. 1993. T-cells and psychopathology in schizophrenia: relationship to the outcome of neuroleptic therapy. Acta Psychiatr. Scand. (Denmark) 87: 66-71
17. 17. Ganguli R., Rabin B.S., Kelly R.H., Lyte M., Ragu U. 1987. Clinical and laboratory evidence of autoimmunity in acute schizophrenia. Annals N.Y. Acad. Sci. 496: 676-685
18. 18. Henneberg A., Riedl B., Dumke H.O., Kornhuber H.H. 1990. T-lymphocyte subpopulations in schizophrenic patients. Eur. Arch. Psychiatry Neurol. Sci. 239: 283-4
19. 19. Muller N., Ackenheil M., Hofschuster E., Mempel W., Eckstein R. 1991. Cellular immunity in schizophrenic patients before and during neuroleptic treatment. Psychiatry Res. 37: 147-60
20. 20. Villemain F., Chatenoud L., Galinowski A., Homo-Delarch F., Ginestet D., Loo H., Zarifian E., Bach J.F. 1989. Abberrant T cell-mediated immunity in untreated schizophrenic patients: deficient interleukin-2 production. Am. J. Psychiatry 146: 609-16
21. 21. Masserini C., Vita A., Basile R., Morselli R., Boato P., Peruzzi C., Pugnetti L., Ferrante P., Cassullo C.L. 1990. Lymphocyte subsets in schizophrenic disorders. Relationship with clinical, neuromorphological and treatment variables. Schizophr. Res. 3: 269-75
22. 22. Muller N., Ackenheil M., Eckstein R., Hofschuster E., Mempel W. 1987. Reduced suppressor cell function in psychiatric patients. Ann. N.Y. Acad. Sci. 496: 686-690
23. 23. McDaniel J.S., Jewart R.D., Eccard M.B., Pollard W.E., Caudle J., Stipetic M., Risby E.D., Lewine R., Risch S.C. 1992. Natural killer cell activity in schizophrenia and schizoaffective disorder: a pilot study. Schizophr. Res. 8: 125-8
24. 24. Caldwell C.L., Irwin M., Lohr J. 1991. Reduced natural killer cell cytotoxicity in depression but not in schizophrenia. Biol. Psychiatry 30: 1131-8
25. 25. Schindler L., Leroux M., Beck J., Moises H.W., Kirchner H. 1986. Studies of cellular immunity, serum interferon titers, and natural killer cell activity in schizophrenic patients. Acta Psychiatr. Scand. 73: 651-7
26. 26. Urch A., Muller C., Aschauer H., Resch F., Zielinski C.C. 1988. Lytic effector cell function in schizophrenia and depression. J. Neuroimmunol. 18: 291-301
27. 27. Monteleone P., Valente B., Maj M., Kemali D. 1991. Reduced lymphocyte response to PHA and OKT3 in drug-free and neuroleptic-treated chronic schizophrenics. Biol. Psychiatry 30: 201-4
28. 28. Ganguli R., Rabi B.S., Belle S.H. 1989. Decreased interleukin-2 production in schizophrenic patients. Biol. Psychiatry 26: 427-30
29. 29. Villemain F., Chatenoud L., Guillibert E., Pelicier Y., Bach J.F. 1987. Decreased production of interleukin-2 in schizophrenia. Ann. N.Y. Acad. Sci. 496: 669-75
30. 30. Gattaz W.F., Dalgalarrondo P., Schroder H.C. 1992. Abnormalities in serum concentrations of interleukin-2, interferon-alpha and interferon-gamma in schizophrenia not detected. Schizophr. Res. 6: 237-41
31. 31. Preble O.T., Torrey E.T. 1985. Serum interferon in patients with psychosis. Am. J. Pscyhiatry 142: 1184-86
32. 32. Becker D., Kritschmann E., Floru S., Shlomo-David Y., Gotrlieb-Stematsky T. 1990. Serum interferon in first psychotic attack. Br. J. Psychiatry 157: 136-8
33. 33. Zarrabi M.H., Zucker S., Miller F., Debman R.M., Romano G.S., Hartnett T.A., Yarma A.O. 1979. Immunologic and coagulation disorders in chlorpromazine-treated patients. Ann. Int. Med. 31: 194-199
34. 34. Yannitsi S.G., Manoussakis M.N., Mavridis A.K., Tzioufas A.G., Loukas S.B., Plataris G.K., Liakos A.D., Moutsopoulos H.M. 1990. Factors related to the presence of autoantibodies in patients with chronic mental disorders. Biol.Psychiatry 27: 747-56
35. 35. Schattner A., Merlin G., Bregman V., Hahn T., Levin S., Revel M., Wallach D. 1984. (2′-5′) Oligo A synthetase in human polymorphonuclear cells increased activity in interferon treatment and in viral infections. Clin. Exp. Immunol. 57: 265-70
36. 36. Libikova H., Breier S., Kocisova M., Pogady J., Stunzer D., Ujhazyova D. 1979. Assay of interferon and viral antibodies in the cerebrospinal fluid in clinical neurology and psychiatry. Acta Biol. Med. Ger. 38: 879-93
37. 37. Moises H.W., Schindler L., Leroux M., Kirchner H. 1985. Decreased production of interferon alpha and interferon gamma in leucocyte cultures of schizophrenic patients. Acta Psychiatr. Scand. 72: 45-50
38. 38. Beutler B. 1988. The presence of cachectin/tumor necrosis factor in human disease states. Am. J. Med. 85: 278-8
39. 39. Schattner A., Steinbock M., Tepper R., Shoenfeld A., Vaisman N., Hahn T. 1990. Tumour necrosis factor production and cell mediated immunity in anorexia nervosa. Clin. Exp. Immunol. 79: 62-66
40. 40. Sawada S., Takei M., Mitamura K. 1994. Soluble CD4/CD8 molecules in rheumatic disorders. Clin. Immunol. Immunopathol 72: 177-180
41. 41. Dunbar P.R., Hill J., Neale T.J., Mellsop G.W. 1992. Neopterin measurement provides evidence of altered cell-mediated immunity in patients with depression, but not with schizophrenia. Psychol. Med. 22: 1051-7
42. 42. Sperner-Unterweger B., Barnas C., Fleischhacker W.W., Fuchs D., Meise U., Reibnegger G., Wachter H. 1989. Is schizophrenia linked to alteration in cellular immunity? Schizophr. Res. 2: 417-21
43. 43. Sperner-Unterweger B., Barnas C., Fuchs D., Kemmler G., Wachter H., Hinterhuber H., Fleschhacker W.W. 1992. Neopterin production in acute schizophrenic patients: an indicator of alterations of cell-mediated immunity. Psychiatry Res. 42: 121-8
44. 44. Henderson D.C., Sheldon J., Riches P., Hobbs J.R. 1991. Cytokine induction of neopterin production. Clin. Exp. Immunol 83: 479-82
45. 45. Fuchs D., Weiss G., Reibnegger G., Wachter H. 1992. The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious and malignant diseases. Crit. Rev. Clin. Lab. Sci. 29: 307-341
46. 46. Romagnani S. 1994. Lymphokine production by human T cells in disease states. Ann. Rev. Immunol. 12: 237-257
47. 47. Angell M. 1989. Negative studies. N. Engl. J. Med. 321: 464-466
48. 48. Noy S., Achiron A., Laor N. 1994. Schizophrenia and autoimmunity - a possible etiological mechanism? Neuropsychobiology 30: 157-159